Author:
Wei Chenyu,Sun Haolin,Hu Jiexuan,Ma Zhongjun,Cao Bangwei
Funder
Capital Health Research and Development of Special Fund
National Natural Science Foundation of China
Beijing Natural Science Foundation
Reference60 articles.
1. Non-small cell lung cancer, Version 3.2022, NCCN clinical practice guidelines in oncology;Ettinger;J. Natl. Compr. Canc. Netw.,2022
2. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology;Gradishar;J. Natl. Compr. Canc. Netw.,2022
3. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology;Ajani;J. Natl. Compr. Canc. Netw.,2022
4. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology;Ajani;J. Natl. Compr. Canc. Netw.,2023
5. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer;Forde;N. Engl. J. Med.,2022